2024
PO0205 Investigation of Inter-Observer Variability of Rectovaginal Reference Point Definition for Cervical Cancer Brachytherapy
Adefres B, Wallington D, Tien C, Damast S. PO0205 Investigation of Inter-Observer Variability of Rectovaginal Reference Point Definition for Cervical Cancer Brachytherapy. Brachytherapy 2024, 23: s96. DOI: 10.1016/j.brachy.2024.08.140.Peer-Reviewed Original ResearchExternal beam radiotherapyTreatment planning systemCervical cancer brachytherapyObserver 1Inter-observer variationObserver 2High dose rate brachytherapyDose gradientCombined external beam radiotherapyExternal beam radiotherapy doseDose measurementsPhysical doseCancer brachytherapyPosterior vaginal wallCervical cancer patientsBrachytherapy techniquesPlanning systemInter-observer differencesInter-observer variabilityBrachytherapy doseCumulative EQD2HDR-BTVaginal doseBeam radiotherapyVaginal wall
2015
High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma
Damast S, Higgins SA, Ratner E, De Leon MC, Mani S, Silasi DA, Azodi M, Santin A, Rutherford T, Schwartz PE. High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma. Journal Of Contemporary Brachytherapy 2015, 7: 35-40. PMID: 25829935, PMCID: PMC4371058, DOI: 10.5114/jcb.2015.48539.Peer-Reviewed Original ResearchRecurrence-free survivalUterine serous carcinomaComprehensive surgical stagingOverall survivalSurgical stagingSerous carcinomaPara-aortic lymph node dissectionFIGO 2009 stage ICarboplatin-paclitaxel chemotherapyInstitutional chart reviewIsolated vaginal recurrencesSimultaneous lung metastasisLymph node dissectionPelvic control rateKaplan-Meier methodRate vaginal brachytherapyCases of recurrenceMedian followNode dissectionPeritoneal cytologyVaginal brachytherapyVaginal recurrenceTotal hysterectomyChart reviewBrachytherapy dose